The AI Revolution in Rare Disease Drug Discovery

A recent announcement by Atomico, one of Europe’s largest venture capital firms based in London, introduced its new partner Healx. The startup can boast of having the world’s most comprehensive…

Continue Reading The AI Revolution in Rare Disease Drug Discovery
How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research
Source: Pixabay

How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research

Rare disease research can feel like an uphill battle. First of all, rare diseases have a harder time receiving funding. After that, it takes months or even years to have…

Continue Reading How Thinking Like a Tech Start Up Led to Strides Forward in NGLY1 Deficiency Research
Close Menu